Moriarty, Maureen A.
Barch, Carol A.
Funding for this research was provided by:
Pfizer
Article History
Received: 12 May 2025
Accepted: 2 June 2025
First Online: 27 June 2025
Declarations
:
: Carol A. Barch served as a consultant for AbbVie and Aptar, Maureen A. Moriarty served as a consultant for AbbVie. Carol A. Barch and Maureen A. Moriarty are on the AbbVie and Pfizer advisory board (March 2024).
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.